GeneDx Holdings Corp. - Class A Common Stock (WGS)
84.87
+0.28 (0.33%)
NASDAQ · Last Trade: Apr 2nd, 7:21 PM EDT
Exploring high growth characteristics of GENEDX HOLDINGS CORP (NASDAQ:WGS). A fundamental and technical analysis of (NASDAQ:WGS).
Via Chartmill · March 20, 2025
A fundamental and technical analysis of (NASDAQ:WGS): Why the high growth investor may take a look at GENEDX HOLDINGS CORP (NASDAQ:WGS).
Via Chartmill · March 18, 2025

In this video lesson I review the day-one of a new rally attempt in the overall market, discuss my new swing trade in a cyber-security leader, and review my tier-one long-term portfolio purchases in my favorite leading stocks before the closing bell.
Via Talk Markets · March 8, 2025
In this video lesson, I review the overall market, the recent bearish sentiment, and one new swing trade idea for Monday's session.
Via Talk Markets · February 28, 2025

Why the high growth investor may take a look at GENEDX HOLDINGS CORP (NASDAQ:WGS).
Via Chartmill · December 11, 2024

GeneDx stock catapulted more than 40% on Tuesday after the top-notch biotech smashed fourth-quarter expectations.
Via Investor's Business Daily · February 18, 2025

Via Benzinga · February 18, 2025

Via Benzinga · February 18, 2025

Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent geopolitical developments and anticipate the release of the latest FOMC minutes on Wednesday.
Via Benzinga · February 18, 2025

Via Benzinga · February 18, 2025

Via Benzinga · February 18, 2025

Top performing mid-cap stocks last week: WRD (+97.62%), GDS (+43.45%), SWTX (+42.58%), RXRX (+40.59%), SOC (+39.09%), WGS (+28.23%), VNET (+28.22%), NSP (+25.99%), CRSP (+25.21%), AXSM (+24.01%)
Via Benzinga · February 16, 2025

Via Benzinga · February 14, 2025

Saying shares of GeneDx skyrocketed in 2024 may be an understatement. As a leader in its market, upside is still a legitimate possibility for this name.
Via MarketBeat · January 27, 2025

Via Talk Markets · January 14, 2025

Stocks gave back all of Monday’s gains and then some today. Monday’s panic buyers were mercilessly punished for going nuts during the spree.
Via Talk Markets · January 8, 2025

GeneDx provides whole and exome gene sequencing to identify rare diseases.
Via Investor's Business Daily · January 6, 2025
There are too many stocks acting well to expect a bear market right now.
Via Talk Markets · January 5, 2025

Energy plays, a biotech and a brokerage also are flashing buy signals or setting up.
Via Investor's Business Daily · January 4, 2025

US stock futures up, GeneDx appoints new COO, Lifecore beats expectations, SPS Commerce acquires Carbon6, Resources Connection & UDR report strong quarters.
Via Benzinga · January 3, 2025

A look at the some of best performing stocks in 2024 of current Russell 3,000 members.
Via Talk Markets · January 2, 2025

These high-fliers are on the leading edge of innovation.
Via Talk Markets · December 19, 2024

Via The Motley Fool · November 16, 2024

If you are interested in the stock market, maybe it is time to stop focusing on The Fed.
Via Talk Markets · November 10, 2024